Financial Arrangements Sample Clauses

Financial Arrangements. 2.1 Pursuant to the budget contained in the Work Plan, UNDP shall make available to the CSO funds up to the maximum amount indicated in block 5 of the Face Sheet upon timely achievement of the Deliverables and in accordance with the schedule set forth in the Work Plan. 2.2 The amounts stated above shall not be subject to any adjustment or revision because of price or currency fluctuations, or the actual costs incurred by the CSO in the implementation of the Activities. 2.3 All payments shall be made by UNDP to the CSO bank account indicated in block 6 of the Face Sheet. 2.4 Payments effected by UNDP to the CSO shall be deemed neither to relieve the CSO of its obligations under this Agreement nor as acceptance by UNDP of the CSO’s performance of the Activities. 2.5 The CSO shall notify UNDP about any expected budget variations. The CSO shall be authorized to make variations not exceeding twenty (20) per cent on any one budget line item in the Work Plan, provided that the maximum amount allocated by UNDP pursuant to paragraph 2.1 above, is not exceeded. Any variations exceeding twenty (20) per cent on any one budget line item that may be necessary for the proper and successful implementation of the Activities under this Agreement shall be subject to prior consultations with, and written approval by, UNDP. 2.6 UNDP shall not be liable for the payment of any expenses, fees, tolls, or any other costs not expressly provided for in the Work Plan, not authorized by UNDP pursuant to the preceding paragraph, or exceeding the maximum amount referred to in paragraph 2.1 above. 2.7 Unless otherwise agreed in writing by UNDP, the CSO shall return all unspent funds and income (including interest) to UNDP within one (1) month of completion of the Activities or termination of this Agreement, whichever is earlier.

Financial Arrangements. The Commonwealth will provide an estimated total financial contribution to the States of up to $9.5 billion (GST exclusive) in respect of this Agreement, as set out in Part 5 – Financial Arrangements.

Financial Arrangements. (a) List the source(s) of assured or anticipated support to be used to cover the general expenses of organizing the exhibition. (b) Describe the nature and amount of loan fees or other contractual arrangements with lenders to the exhibition in excess of $10,000 for the entire exhibition.

Financial Arrangements. Compensation for services provided under this Agreement will be made by way of payments in accordance with Attachment A (Payment Terms) and Attachment B (Financial Arrangements Worksheet). All Parties acknowledge that amounts set forth in Attachment B represent fair market value of the services provided by Provider and Principal Investigator for conducting the Trial to the best of their knowledge. All amounts are inclusive of all direct, indirect, overhead and other costs, including laboratory and ancillary service charges, and will remain firm for the duration of the Trial, unless otherwise agreed in writing by the Parties. Neither the Provider nor the Principal Investigator will directly or indirectly seek or receive compensation from Trial Subjects or third-party payers for any material, treatment or service that is required by the Protocol and provided or paid by Sponsor or its designee, including, but not limited to, Sponsor Drug, Comparator Drug, Trial Subject screening, infusions, physician and nurse services, diagnostic tests, and Sponsor Drug and/or Comparator Drug administration. Once the designated payees have been paid for the performance of the Trial, neither CRO nor Sponsor shall have any further obligation or liability 5. Finanční ujednání. Odměna za služby poskytované dle této smlouvy bude vyplacena prostřednictvím úhrad v souladu s přílohou A (platební podmínky) a přílohou B (záznam finančního ujednání). Všechny strany berou na vědomí, že částky uvedené v příloze B představují spravedlivou tržní hodnotu služeb poskytovaných poskytovatelem a hlavním zkoušejícím při provádění klinického hodnocení dle jejich nejlepšího vědomí. Všechny částky zahrnují všechny přímé, nepřímé, režijní a další náklady, včetně nákladů na laboratorní a pomocné služby a zůstanou pevné po dobu trvání klinického hodnocení, pokud se strany písemně nedohodnou jinak. Poskytovatel ani hlavní zkoušející nebudou přímo ani nepřímo vyžadovat ani přijímat odměnu od subjektů klinického hodnocení nebo plátců třetích stran za materiály, léčbu nebo služby vyžadované podle protokolu a poskytnuté nebo zaplacené zadavatelem nebo jeho zástupcem, včetně zejména hodnoceného léčivého přípravku, srovnávacího léku, screeningu subjektů klinického hodnocení, infuzí, služeb lékařů a sester, diagnostických testů a podávání hodnoceného léčivého přípravku a/nebo srovnávacího léku. Jakmile bude určeným příjemcům plateb uhrazeno provádění whatsoever to pay Principal Investigator or Provider. klini...

Financial Arrangements. The financing of my participation in the Deferred Salary Leave Plan shall be according to the following schedule:

Financial Arrangements. 10.1 Arrangements relating to the financing of this Clinical Trial by the Sponsor are set out in Appendix 6 hereto. 10.2 In the event that amendments to the Protocol require changes to the trial financing arrangements, an amended financial schedule will be signed by the Parties pursuant to clause 14.2 below and attached as a supplement at Appendix 6 of this Agreement. 10.3 All payments will be made according to the schedule contained in Appendix 6 on presentation of a VAT invoice from the Trust to the Party making payment. 10.4 The Party making payment shall promptly respond to any reasonable request for invoicing data received from the Trust within 45 days of the close-out of the Trial Site. The Trust will send its final invoice, (or, as the case may be, issue a credit note and make repayment of any monies previously paid for work not completed), to the party making payment as soon as possible and, in any event, within 45 days of receipt of the said data where such a request has been made, or within 45 days of study close-out in all other circumstances unless there is a written agreement between the Trust and the Party making payment to extend these periods. 10.5 The Party making payment shall do so within forty-five (45) days of the date of receipt of the invoice mentioned in clause 10.3 above. 10.6 Any delay in the payment of the payee invoices by a Party will incur an interest charge on any amounts overdue of 2 per cent per month above the National Westminster Bank plc base rate prevailing on the date the payment is due.

Financial Arrangements. 1. This Memorandum of Understanding will not give rise to any financial obligation by one Party to other. 2. Each Party will bear its own cost and expenses in relation to this Memorandum of Understanding.

Financial Arrangements. When the Trust is not the Investigator’s principal employer, this should include, after the schedule of payments, the statement that: It shall be the responsibility of the Trust to make the appropriate agreed pass-through payments to the Investigator’s principal employer, as indicated above.

Financial Arrangements. When the Board is not the Investigator’s principal employer, this should include, after the schedule of payments, the statement that: It shall be the responsibility of the Board to make the appropriate agreed pass-through payments to the Investigator’s principal employer, as indicated above.